Elisabetta Bonzano/X
Jan 29, 2025, 09:43
Elisabetta Bonzano: Safety of topical estrogen during adjuvant endocrine therapy in breast cancer patients
Elisabetta Bonzano, Radiation Oncologist at IRCCS San Matteo Polyclinic Foundation, shared an article on X authored by Stavroula L. Kastora et al.:
“Safety of topical estrogen therapy during adjuvant endocrine treatment among patients with breast cancer: A meta-analysis based expert panel discussion
Topical oestrogen use does not appear to increase recurrence or mortality risk in breast cancer survivors on tamoxifen.
Topical oestrogen use during aromatase inhibitors may raise recurrence risk, though mortality risk appears unaffected.
An adequately powered prospective study with extended follow-up is recommended to resolve clinical uncertainty on recurrence.”
Authors: Stavroula L. Kastora et al.
Andreas Karakatsanis
Ann H. Partridge
Ann Knoop
Barbro Linderholm
cancer
Denise Vorburger
Eirini Pantiora
Elisabetta Bonzano
Gabriella Yongue
Hatem A Azim
Icro Meattini
Ines Vaz-Luis
Jürgen Geisler
Matteo Lambertini
Meenakshi Veeramani
OncoDaily
Oncology
Rima Chakrabarti
Stavroula L. Kastora
Yong Hwa Hong
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jan 29, 2025, 09:43
Jan 29, 2025, 09:40
Jan 29, 2025, 09:39
Jan 29, 2025, 08:23
Jan 29, 2025, 08:18
Jan 29, 2025, 08:15
Jan 29, 2025, 08:13